SymBioVault and CoreLedger presented a joint concept at CV Summit 2026, exploring the potential use of blockchain technology in personalized microbiome biobanking.
The conference took place on 29–30 September 2026 at Kongresshaus Zurich, bringing together participants from the digital assets, blockchain and technology sectors.
During the session “Real Business Problems. Real Blockchain Solutions.”, Dr. Pavel Timofeev, Founder and Medical Lead of SymBioVault, and Dr. Johannes Schweifer, CEO of CoreLedger, presented their joint concept.
The presentation addressed the potential use of blockchain-based infrastructure for documenting sample provenance, traceability and individual control over preserved biological material.
SymBioVault has joined Technologie Forum Zug (tfz), strengthening our connections within Zug’s technology and innovation ecosystem and creating new opportunities for exchange and collaboration across business, technology and research.
SymBioVault and ZHAW have launched a Proof-of-Concept study exploring the collection, analysis and long-term cryopreservation of personal microbiome samples - an important step toward scientifically validated microbiome biobanking.